ArticleFrontiers in pharmacology2025
Evaluating the risk of osteoporosis-related adverse events with proton pump inhibitors: a pharmacovigilance study.
Jingkai Di et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it